Gartner, Inc. Cash and Cash Equivalents, Period Increase (Decrease)
Gartner, Inc. (IT) reported Cash and Cash Equivalents, Period Increase (Decrease) of $125.30 million for the 12-month period ending 2013-12-31, per its 10-K filed 2014-02-26.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2014-02-26
- Gartner, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2013-12-31 was $48.86M, a 12.76% increase year-over-year.
- Gartner, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2013-09-30 was $36.85M, a 62.80% decline year-over-year.
- Gartner, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2013-06-30 was $66.46M, a 310.54% increase year-over-year.
- Gartner, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2013-03-31 was -$26.86M.
- Gartner, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2013 was $125.30M, a 17.87% decline from fiscal 2012.
- Gartner, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2012 was $152.57M, a 463.97% increase from fiscal 2011.
- Gartner, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2011 was $27.05M, a 27505.10% increase from fiscal 2010.
- Gartner, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2010 was $98.00K.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2013-12-31 | $48.86M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26 | $85.70M derived: sum of 2 quarters · filed 2014-02-26 | $152.16M derived: sum of 3 quarters · filed 2014-02-26 | $125.30M 10-K · filed 2014-02-26 |
| 2013-09-30 | $36.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $103.31M derived: sum of 2 quarters · filed 2013-11-07 | $76.44M 10-Q · filed 2013-11-07 | $119.77M derived: sum of 4 quarters · filed 2014-02-26 |
| 2013-06-30 | $66.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-02 | $39.60M 10-Q · filed 2013-08-02 | $82.93M derived: sum of 3 quarters · filed 2014-02-26 | $181.97M derived: sum of 4 quarters · filed 2014-02-26 |
| 2013-03-31 | -$26.86M 10-Q · filed 2013-05-02 | $16.47M derived: sum of 2 quarters · filed 2014-02-26 | $115.52M derived: sum of 3 quarters · filed 2014-02-26 | $131.70M derived: sum of 4 quarters · filed 2014-02-26 |
| 2012-12-31 | $43.33M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26 | $142.38M derived: sum of 2 quarters · filed 2014-02-26 | $158.56M derived: sum of 3 quarters · filed 2014-02-26 | $152.57M 10-K · filed 2014-02-26 |
| 2012-09-30 | $99.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $115.24M derived: sum of 2 quarters · filed 2013-11-07 | $109.24M 10-Q · filed 2013-11-07 | $94.69M derived: sum of 4 quarters · filed 2014-02-26 |
| 2012-06-30 | $16.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-02 | $10.19M 10-Q · filed 2013-08-02 | -$4.36M derived: sum of 3 quarters · filed 2014-02-26 | $32.52M derived: sum of 4 quarters · filed 2014-02-26 |
| 2012-03-31 | -$6.00M 10-Q · filed 2013-05-02 | -$20.55M derived: sum of 2 quarters · filed 2014-02-26 | $16.33M derived: sum of 3 quarters · filed 2014-02-26 | $31.64M derived: sum of 4 quarters · filed 2014-02-26 |
| 2011-12-31 | -$14.55M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26 | $22.33M derived: sum of 2 quarters · filed 2014-02-26 | $37.63M derived: sum of 3 quarters · filed 2014-02-26 | $27.05M 10-K · filed 2014-02-26 |
| 2011-09-30 | $36.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $52.19M derived: sum of 2 quarters · filed 2012-11-06 | $41.60M 10-Q · filed 2012-11-06 | $13.21M derived: sum of 4 quarters · filed 2013-02-22 |
| 2011-06-30 | $15.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | $4.72M 10-Q · filed 2012-08-03 | -$23.67M derived: sum of 3 quarters · filed 2013-02-22 | -$8.64M derived: sum of 4 quarters · filed 2013-02-22 |
| 2011-03-31 | -$10.58M 10-Q · filed 2012-05-03 | -$38.98M derived: sum of 2 quarters · filed 2013-02-22 | -$23.95M derived: sum of 3 quarters · filed 2013-02-22 | -$2.14M derived: sum of 4 quarters · filed 2013-02-22 |
| 2010-12-31 | -$28.39M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22 | -$13.36M derived: sum of 2 quarters · filed 2013-02-22 | $8.44M derived: sum of 3 quarters · filed 2013-02-22 | $98.00K 10-K · filed 2013-02-22 |
| 2010-09-30 | $15.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-01 | $36.84M derived: sum of 2 quarters · filed 2011-11-01 | $28.49M 10-Q · filed 2011-11-01 | $32.76M derived: sum of 4 quarters · filed 2012-02-23 |
| 2010-06-30 | $21.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-02 | $13.46M 10-Q · filed 2011-08-02 | $17.73M derived: sum of 3 quarters · filed 2012-02-23 | $26.51M derived: sum of 4 quarters · filed 2012-02-23 |
| 2010-03-31 | -$8.34M 10-Q · filed 2011-05-05 | -$4.08M derived: sum of 2 quarters · filed 2012-02-23 | $4.71M derived: sum of 3 quarters · filed 2012-02-23 | |
| 2009-12-31 | $4.26M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23 | $13.05M derived: sum of 2 quarters · filed 2012-02-23 | -$31.51M 10-K · filed 2012-02-23 | |
| 2009-09-30 | $8.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-03 | -$35.77M 10-Q · filed 2010-11-03 | ||
| 2009-06-30 | -$44.56M 10-Q · filed 2010-08-09 | |||
| 2008-12-31 | $48.06M 10-K · filed 2011-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evolent Health, Inc. (EVH) | United States | $0.397B | -1.21 |
| FRANKLIN COVEY CO (FC) | United States | $0.195B | 123.76 |